TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma

Clear cell renal cell carcinoma (ccRCC) is one of the most common urological malignancies. Identifying novel biomarkers and investigating the underlying mechanism of ccRCC development will be crucial to the management and treatment of ccRCC in patients. Thymosin b10 (TMSB10), a member of the thymosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Qiufeng, Cheng, Gong, Liu, Yuenan, Xu, Tianbo, Zhang, Hao, Li, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115359/
https://www.ncbi.nlm.nih.gov/pubmed/32319572
http://dx.doi.org/10.3892/ijo.2020.4991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115359/
https://www.ncbi.nlm.nih.gov/pubmed/32319572
http://dx.doi.org/10.3892/ijo.2020.4991

Ejemplares similares